你即將離開本站

並前往https://diabetes.acponline.org/archives/2019/09/13/6.htm

Canagliflozin reduced kidney failure and CV events at 2.6 ...

Canagliflozin reduced risk for kidney failure and CV events. These findings are consistent with the CANVAS program and EMPA-REG trials, ...

確定！ 回上一頁

查詢 「EMPA-KIDNEY」的人也找了：

  1. Cana CKD
    2.
  2. Empagliflozin CKD
    3.
  3. EMPEROR-Reduced
    4.
  4. EMPEROR-Preserved
    5.
  5. CANVAS trial
    6.
  6. EMPA-REG renal outcome
    7.
  7. Dapagliflozin renal outcome
    8.
  8. Nejm kidney
    9.